Products - Diabetes | Topic | NICE

Showing 7 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Dulaglutide for treating type 2 diabetes [ID1451]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ranibizumab port delivery system for treating diabetic macular oedema [ID6137]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Semaglutide for treating type 2 diabetes [ID1450]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sotagliflozin for treating type 2 diabetes [ID1657]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tirzepatide for reducing the risk of major adverse cardiovascular events in people with type 2 diabetes and cardiovascular disease [TSID12347]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tirzepatide for treating type 2 diabetes in people 10 to 17 years [ID6539]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Zimislecel for treating type 1 diabetes in people 12 years and over with impaired hypoglycaemic awareness and severe hypoglycaemia [ID6624]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC